WallStreetZenWallStreetZen

NASDAQ: LKFT
Lakefront Biotherapeutics Nv Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lakefront Biotherapeutics Nv earnings were $575.0M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest LKFT earnings report on Mar 31, 2026 announced Q1 2026 earnings of $16.7M, down 98.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LKFT reported annual earnings of $377.5M, with 389.2% growth.

LKFT earnings history

Current Revenue
$1.1B
Current Earnings
$561.8M
Current Profit Margin
49.7%

LKFT Return on Equity

Current Company
16.9%
Current Industry
-145.3%
Current Market
5.2%
LKFT's Return on Equity (16.9%)... subscribe to Premium to read more.
High Return on Equity Performance

LKFT Return on Assets

Current Company
13.9%
Current Industry
-9.7%
LKFT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LKFT announces earnings.

LKFT Return on Capital Employed

Current Company
14.43%
Current Industry
-5.8%

LKFT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LKFTN/A$575.03MN/AN/A
ADMA$221.54M$165.35M-21.59%$0.69
TYRA-$119.40M-$119.95MN/A-$2.01
CAPR-$100.11M-$105.04MN/A-$2.26
RAPP-$104.07M-$107.28MN/A-$2.59
View Top Biotech Stocks

Lakefront Biotherapeutics Nv Earnings Reports & History FAQ

What were Lakefront Biotherapeutics Nv's earnings last quarter?

On LKFT's earnings call on Invalid Date, Lakefront Biotherapeutics Nv (NASDAQ: LKFT) reported Q1 2026 earnings per share (EPS) of $0.25, up 109.99% year over year. Total LKFT earnings for the quarter were $16.66 million. In the same quarter last year, Lakefront Biotherapeutics Nv's earnings per share (EPS) was -$2.53.

If you're new to stock investing, here's how to buy Lakefront Biotherapeutics Nv stock.

Is Lakefront Biotherapeutics Nv profitable or losing money?

As of the last Lakefront Biotherapeutics Nv earnings report, Lakefront Biotherapeutics Nv is currently profitable. Lakefront Biotherapeutics Nv's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $561.81 million, a 404.86% decrease year over year.

What was LKFT's earnings growth in the past year?

As of Lakefront Biotherapeutics Nv's earnings date in Invalid Date, Lakefront Biotherapeutics Nv's earnings has grown year over year. LKFT earnings in the past year totalled $575.03 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.